The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year
- PMID: 35279968
- PMCID: PMC10009062
- DOI: 10.3393/ac.2021.00696.0099
The pattern of bowel dysfunction in patients with rectal cancer following the multimodal treatment: anorectal manometric measurements at before and after chemoradiation therapy, and postoperative 1 year
Abstract
Purpose: Bowel dysfunction commonly occurs in patients with locally advanced rectal cancer treated with a multimodal approach of chemoradiation therapy (CRT) combined with sphincter-preserving rectal resection. This study investigated the decline in anorectal function using sequential anorectal manometric measurements obtained before and after the multimodal treatment as well as at a 1-year follow-up.
Methods: This was a retrospective cohort study conducted in a single center. The study population consisted of patients with locally advanced mid- to low rectal cancer who received the preoperative CRT followed by sphincter-preserving surgery from 2012 to 2016. The anorectal manometric value measured after each treatment modality was compared to demonstrate the degree of decline in anorectal function. A generalized linear model of repeated measures was performed using the manometric values measured pre- and post-CRT, and at 12 months postoperatively.
Results: Overall, 100 patients with 3 consecutive manometric data were included in the final analysis. In the overall cohort study, the mean resting and maximal squeezing pressures showed insignificant decrement post-neoadjuvant CRT. At a 1-year postoperative follow-up, the maximal squeezing pressure significantly decreased. The maximal rectal sensory threshold demonstrated significant reduction consecutively after each following treatment (P<0.001).
Conclusion: The short-term effect of neoadjuvant CRT on the anal sphincters was relatively trivial. The following sphincter-saving surgery resulted in a profound disruption of the anorectal function. Patients with rectal cancer should be consulted on the consequence of multimodal treatment.
Keywords: Combined modality therapy; Fecal incontinence; Manometry; Proctectomy; Rectal neoplasms.
Conflict of interest statement
No potential conflict of interest relevant to this article was reported.
Figures
Similar articles
-
Manometric evaluation of anorectal function in patients treated with neoadjuvant chemoradiotherapy and total mesorectal excision for rectal cancer.Dig Liver Dis. 2017 Jan;49(1):91-97. doi: 10.1016/j.dld.2016.09.005. Epub 2016 Sep 22. Dig Liver Dis. 2017. PMID: 27720700
-
The value of posterior levator repair in the treatment of anorectal incontinence due to rectal prolapse--a clinical and manometric study.Langenbecks Arch Surg. 2001 Apr;386(3):188-92. doi: 10.1007/s004230100223. Langenbecks Arch Surg. 2001. PMID: 11382320
-
Peri-treatment change of anorectal function in patients with rectal cancer after preoperative chemoradiotherapy.Oncotarget. 2017 Aug 27;8(45):79982-79990. doi: 10.18632/oncotarget.20567. eCollection 2017 Oct 3. Oncotarget. 2017. PMID: 29108380 Free PMC article.
-
Anal function after endoluminal locoregional resection by transanal endoscopic microsurgery and radiotherapy for rectal cancer.Colorectal Dis. 2017 Jun;19(6):O177-O185. doi: 10.1111/codi.13656. Colorectal Dis. 2017. PMID: 28304143
-
Anorectal endosonography in benign anorectal disorders.Scand J Gastroenterol Suppl. 1993;200:70-3. doi: 10.3109/00365529309101579. Scand J Gastroenterol Suppl. 1993. PMID: 8016575 Review.
Cited by
-
Unveiling the profound advantages of total neoadjuvant therapy in rectal cancer: a trailblazing exploration.Ann Surg Treat Res. 2023 Dec;105(6):341-352. doi: 10.4174/astr.2023.105.6.341. Epub 2023 Nov 29. Ann Surg Treat Res. 2023. PMID: 38076602 Free PMC article. Review.
-
Analgesic effect of structured anal skin care for perianal dermatitis after low anterior resection in the rectal cancer patients: prospective, single-center, open-label, therapeutic confirmatory, randomized clinical trial.Ann Surg Treat Res. 2022 Dec;103(6):360-371. doi: 10.4174/astr.2022.103.6.360. Epub 2022 Dec 8. Ann Surg Treat Res. 2022. PMID: 36601338 Free PMC article.
-
Beyond survival: a comprehensive review of quality of life in rectal cancer patients.Ann Coloproctol. 2024 Dec;40(6):527-537. doi: 10.3393/ac.2024.00745.0106. Epub 2024 Dec 20. Ann Coloproctol. 2024. PMID: 39748551 Free PMC article. Review.
References
-
- Havenga K, Enker WE, Norstein J, Moriya Y, Heald RJ, van Houwelingen HC, et al. Improved survival and local control after total mesorectal excision or D3 lymphadenectomy in the treatment of primary rectal cancer: an international analysis of 1411 patients. Eur J Surg Oncol. 1999;25:368–74. - PubMed
-
- Bosset JF, Collette L, Calais G, Mineur L, Maingon P, Radosevic-Jelic L, et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med. 2006;355:1114–23. - PubMed
-
- Chen TY, Wiltink LM, Nout RA, Meershoek-Klein Kranenbarg E, Laurberg S, Marijnen CA, et al. Bowel function 14 years after preoperative short-course radiotherapy and total mesorectal excision for rectal cancer: report of a multicenter randomized trial. Clin Colorectal Cancer. 2015;14:106–14. - PubMed
-
- Downing A, Glaser AW, Finan PJ, Wright P, Thomas JD, Gilbert A, et al. Functional outcomes and health-related quality of life after curative treatment for rectal cancer: a population-level study in England. Int J Radiat Oncol Biol Phys. 2019;103:1132–42. - PubMed
LinkOut - more resources
Full Text Sources
Research Materials